BMJ global healthHumansHealth Services AccessibilityIntellectual PropertyCOVID-19Health Policy
TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024.
Montgomery Dunn, Ellen 't Hoen, Pascale Boulet, Kaitlin Mara, Katrina Perehudoff
Published: 202610.1136/bmjgh-2025-021481
Abstract
INTRODUCTION: Millions of people lack access to safe and effective pharmaceuticals because they are unaffordable or unavailable, particularly in 'developing' and 'least-developed' countries (DCs, LDCs), and increasingly in high-income countries (HICs…
Preview only. Read the full abstract at the source